Astellas & Bayer Healthcare three-time finalists at eyeforpharma Barcelona Awards

As the finalists for the inaugural eyeforpharma Barcelona Awards are announced Astellas & Bayer Healthcare are favourites to be winners with three shortlisted projects each.

Both companies have two shortlisted projects for ‘Most valuable patient initiative’ with Astellas also being recognised in the ‘Most impactful emerging or global initiative’ category, and Dallas Moores of Bayer Canada shortlisted for the ‘Customer Innovator Award’.

Grünenthal have also excelled in this category, with Karsten Haas, Vice President & Head of Marketing for Palexia and Narcotic Pain Portfolio and Konrad Labuschagne, Head Governmental Affairs & Health Policy both shortlisted for this award.

A comprehensive list of finalists and their project videos can be found online here: http://www.eyeforpharma.com/barcelona/awards-finalists.php

The very first eyeforpharma Barcelona Awards, sponsored by IMS Health, will take place on Tuesday 18th March at the CCIB, Barcelona from 7.30pm, to be held as part of the largest gathering of pharma executives, eyeforpharma Barcelona. The evening will be attended by the top 200 VIPs from the pharma industry.

For more information contact Awards Manager, Chloe Leighton on chloe@eyeforpharma.com or visit www.eyeforpharma.com/barcelona/awards